Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Status unconfirmed · Phase 1

Conditions studied: Brain and Central Nervous System Tumors, Metastatic Cancer

In brief

RATIONALE: Photodynamic therapy uses light and photosensitizing drugs to kill tumor cells and may be an effective treatment for refractory brain tumors. PURPOSE: This phase I trial is studying the side effects and best dose of photodynamic therapy using porfimer sodium in treating patients with refractory brain tumors, including astrocytoma, ependymoma, and medulloblastoma.

Key facts

Study ID

NCT00002647

Run by

Medical College of Wisconsin

People needed

24

Starts

1994-05-01

Last updated by the study team

2013-09-20

Who can join

Age: 3 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Medical College of Wisconsin Cancer Center — Milwaukee, Wisconsin, United States (enrolling)
• Midwest Children's Cancer Center at Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.